CNBC October 9, 2024
Key Points
– CVS Health and UnitedHealth Group are demanding that FTC Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the company and other drug middlemen of boosting their profits while inflating insulin costs for Americans.
– The companies argued that all three commissioners have an extensive track record of making public statements that indicate “serious bias” against the companies’ so-called pharmacy benefit managers.
– The FTC filed the suit last month against the three largest PBMs, CVS Health’s Caremark, UnitedHealth Group’s Optum Rx and Cigna’s Express Scripts.
CVS Health and UnitedHealth Group are demanding Federal Trade Commission Chair Lina Khan and two other commissioners recuse themselves from a suit accusing the companies and other...
Today's Sponsors
Today's Sponsor